Healthy adults
Conditions
Interventions
Ingestion 0mg of test compounds for 12 weeks.
Ingestion 5mg of test compounds for 12 weeks.
Ingestion 50mg of test compounds for 12 weeks.
Sponsors
Yaizu Suisankagaku Industry Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Males and females aged 20 to 64 years old 2.Subjects who can make self-judgment and are voluntarily giving written informed consent 3.Subjects who are aware of allergic symptoms or have been diagnosed with an allergy
Exclusion criteria
Exclusion criteria: 1.Subjects who have shrimp and/or crab allergy 2.Subjects who are under treatment or have a history of disease such as serious cardiovascular disease and digestive system disease 3.Subjects who continuously use functional foods claimed the anti-allergic effects (e.g., methylated catechins, plant-derived lactic acid bacteria K-2, or Lactobacillus strain L-92). 4.Subjects who are judged as unsuitable for the study by the test administrator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total IgE level | — |
Secondary
| Measure | Time frame |
|---|---|
| Cedar-specific IgE level Cypress-specific IgE level House dust-specific IgE level Thymus and Activation-Regulated Chemokine Eosinophil percentage Allergy-related cytokines Allergy symptom score Medication score Japanese allergic rhinitis standard quality of life questionnaire Blood biochemical test | — |
Countries
Japan
Contacts
Public ContactEriko Nagashima
Yaizu Suisankagaku Industry Co., Ltd. Research & Development Dept.
Outcome results
None listed